ZVSA fundamentals

An in-depth look to ZyVersa Therapeutics, Inc. operating, investing, and financing activities

ZVSA free cash flow for Q1 25 is -1.77 M USD. For 2024, ZVSA free cash flow was -7.56 M USD and operating cash flow was -7.56 M USD.

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: USD